Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-07, with 32 holding rows worth $484,438,000.

Accession
0001567619-20-014483
Filed
2020-08-07
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 32 entries on the cover page, a total value of $484,438,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $484,438,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM644,533$37,899,000thousands by filing date
Gilead Sciences,Inc.375558103COM433,784$33,375,000thousands by filing date
Merck & Co.,Inc.58933Y105COM401,595$31,055,000thousands by filing date
INCYTE CORP COM45337C102Stock275,987$28,694,000thousands by filing date
REVVITY INC714046109COM257,722$25,280,000thousands by filing date
Boston Scientific Corporation101137107COM711,482$24,980,000thousands by filing date
Medtronic PlcG5960L103COM266,800$24,466,000thousands by filing date
Abbott Laboratories002824100COM261,939$23,949,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM172,780$19,393,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock206,616$18,259,000thousands by filing date
Elevance Health, Inc.036752103COM69,002$18,146,000thousands by filing date
NUVASIVE INC670704105COM311,628$17,345,000thousands by filing date
BIOGEN INC COM09062X103Stock64,220$17,182,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock290,593$16,061,000thousands by filing date
HUMANA INC COM444859102Stock36,457$14,136,000thousands by filing date
BRUKER CORP116794108COM337,346$13,723,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM108,482$13,380,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM234,792$12,254,000thousands by filing date
BIO RAD LABS INC090572207CL A26,270$11,861,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock189,981$11,201,000thousands by filing date
PATTERSON COS INC703395103COM466,487$10,263,000thousands by filing date
CVS Health Corporation126650100COM143,416$9,318,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM108,734$8,505,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock54,906$6,257,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock41,684$6,174,000thousands by filing date
CERNER CORP156782104COM85,300$5,847,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock257,891$5,532,000thousands by filing date
LIVANOVA PLCG5509L101SHS109,110$5,251,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM90,396$4,587,000thousands by filing date
Johnson & Johnson478160104COM30,279$4,258,000thousands by filing date
HCA Healthcare Inc40412C101COM35,276$3,424,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM353,085$2,383,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-20-014483this filing2020-08-07acceptance time not in the bulk data set